Rationale and Objectives
Ductal changes are described as a finding of surrounding tissues in breast masses according to the Breast Imaging Reporting and Data System – Ultrasound. However, ductal changes are often found as an isolated finding without a mass on ultrasound. The purpose of this study was to investigate the clinical significance of abnormal ductal dilatations without masses on breast ultrasound.
Materials and Methods
From August 2006 to August 2008, 75 pathologically verified pure ductal dilatations without associated masses on breast ultrasound were collected. Ultrasound findings including the diameter and length of the duct, the presence of ductal wall thickening and intraluminal content, the echo pattern of intraluminal content, and distribution were evaluated. The ultrasound findings were correlated with clinical and pathologic features, and radiologic differences between benign and malignant lesions were assessed using Fisher’s exact tests.
Results
Of the 75 cases with abnormal ductal dilatations, seven (9%) were malignant, and four (5%) were atypical ductal hyperplasia. Ductal dilatations were longer in malignancies than in benign lesions ( P < .05). Ductal wall thickening was more frequent in malignancies (100%) and atypical ductal hyperplasia (50%) than in other benign lesions (3%) ( P < .05). Hypoechoic intraluminal content was more common in malignancies (86%) and atypical ductal hyperplasia (50%) than in other benign lesions (8%) ( P < .05). Furthermore, a segmental distribution was more frequent in malignancies (43%) than in benign lesions (1%). Clinical symptoms were also frequent in malignancies (86%) than in benign lesions (4%) ( P < .05).
Conclusions
Abnormal ductal dilatations without masses have a 9% malignancy rate, and these would be recommended to undergo biopsy as suspicious abnormalities according to Breast Imaging Reporting and Data System – Ultrasound. Ultrasound has an essential role in the assessment of abnormal ducts for distinguishing benign and malignant ductal changes.
In the first edition of the Breast Imaging Reporting and Data System (BI-RADS) – Ultrasound, ductal changes are defined as abnormal caliber and/or arborization and belong to findings of surrounding tissues for breast masses . The significance and clinical management of ultrasound-detected ductal dilatations and the positive predictive value for malignancies or high-risk lesions have been less commonly reported in the past . Also, BI-RADS – Ultrasound does not provide detailed explanations about how to assess abnormal ducts, and it does not provide recommended clinical guidelines. The clinical significance of abnormal ductal dilatations on mammography or magnetic resonance imaging is known, and ductal dilatations have a wide spectrum of pathologic diagnoses, from benign lesions including fibrocystic changes, intraductal papilloma, or ductal hyperplasia to carcinomas . Recently, Hsu et al performed a retrospective study of dilated ducts on breast ultrasound and demonstrated that the positive predictive value for malignancy ranged from 9% to 43% according to the presence of associated masses, multiplicity, or intraductal content.
Pure ductal dilatations without associated masses of the breast are frequently found on breast ultrasound examinations, because ultrasound has been widely used as a screening modality or an adjuvant tool following mammography . Physicians often hesitate to decide on the possibility of malignancy when they encounter pure ductal dilatations on breast ultrasound because of the lack of previous studies and experience.
Get Radiology Tree app to read full this article<
Materials and methods
Study Population
Get Radiology Tree app to read full this article<
Image Analysis
Get Radiology Tree app to read full this article<
Get Radiology Tree app to read full this article<
Pathologic Examinations
Get Radiology Tree app to read full this article<
Statistical Analysis
Get Radiology Tree app to read full this article<
Results
Get Radiology Tree app to read full this article<
Get Radiology Tree app to read full this article<
Table 1
Correlation of Clinical Symptoms with Pathologic Findings in 75 Ductal Lesions
Clinical Symptom Malignancy
( n = 7) Proliferative Lesion with Atypia ( n = 4) Proliferative Lesion without Atypia ( n = 11) Nonproliferative Lesion
( n = 53) Palpable lump 2 (29%) 0 (0%) 0 (0%) 0 (0%) Nipple discharge 4 (57%) 1 (25%) 0 (0%) 1 (2%) Pain 0 (0%) 0 (0%) 0 (0%) 1 (2%) None 1 (14%) 3 (75%) 11 (100%) 51 (96%)
Get Radiology Tree app to read full this article<
Get Radiology Tree app to read full this article<
Table 2
Correlation of Mammographic and Pathologic Findings in 60 Ductal Lesions
Mammographic Finding Malignancy
( n = 7) Proliferative Lesion with Atypia ( n = 4) Proliferative Lesion without Atypia ( n = 9) Nonproliferative Lesion
( n = 40) Mass 0 (0%) 0 (0%) 1 (11%) 1 (2%) Asymmetric density 2 (29%) 1 (25%) 1 (11%) 2 (5%) Calcifications 1 (14%) 0 (0%) 0 (0%) 0 (0%) None 4 (57%) 3 (75%) 7 (78%) 37 (93%)
Get Radiology Tree app to read full this article<
Get Radiology Tree app to read full this article<
Table 3
Correlation of Ultrasound Findings with Pathologic Diagnoses in 75 Ductal Lesions
Pathologic Diagnosis Mean Diameter of the Duct (mm) Length of the Duct (mm) Presence of Ductal Wall Thickening Presence of Intraluminal Content Hypoechoic Intraluminal Content Segmental Distribution Malignancy ( n = 7) 3.1 32.4 7 (100%) 7 (100%) 6 (86%) 3 (43%) Proliferative lesion with atypia ( n = 4) 2.6 27.5 2 (50%) 4 (100%) 2 (50%) 1 (25%) Proliferative lesion without atypia ( n = 11) 2.9 18.9 2 (18%) 9 (82%) 2 (18%) 0 (0%) Nonproliferative lesion ( n = 53) 2.5 18.3 0 (0%) 36 (68%) 3 (8%) 0 (0%)
Get Radiology Tree app to read full this article<
Get Radiology Tree app to read full this article<
Get Radiology Tree app to read full this article<
Discussion
Get Radiology Tree app to read full this article<
Get Radiology Tree app to read full this article<
Get Radiology Tree app to read full this article<
Get Radiology Tree app to read full this article<
Conclusions
Get Radiology Tree app to read full this article<
References
1. American College of Radiology: Breast Imaging Reporting and Data System (BI-RADS).1993.American College of RadiologyReston, VA
2. Sardanelli F., Imperiale A., Zandrino F., et. al.: Breast intraductal masses: US-guided fine-needle aspiration after galactography. Radiology 1997; 204: pp. 143-148.
3. Lazarus E., Mainiero M.B., Schepps B., et. al.: BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value. Radiology 2006; 239: pp. 385-391.
4. Sotome K., Yamamoto Y., Hirano A., et. al.: The role of contrast enhanced MRI in the diagnosis of non-mass image-forming lesions on breast ultrasonography. Breast Cancer 2007; 14: pp. 371-380.
5. Huynh P.T., Parellada J.A., de Paredes E.S., et. al.: Dilated duct pattern at mammography. Radiology 1997; 204: pp. 137-141.
6. Hsu H.H., Yu J.C., Hsu G.C., et. al.: Ultrasonographic alterations associated with the dilatation of mammary ducts: feature analysis and BI-RADS assessment. Eur Radiol 2010; 20: pp. 293-302.
7. Buchberger W., DeKoekkoek-Doll P., Springer P., et. al.: Incidental findings on sonography of the breast: clinical significance and diagnostic workup. AJR Am J Roentgenol 1999; 173: pp. 921-927.
8. D’Orsi C.J., American College of Radiology: Breast Imaging Reporting and Data System: breast imaging atlas: mammography, breast ultrasound, breast MR imaging.4th ed.2003.American College of RadiologyReston, VA
9. Tavassoli F.A.: Infiltrating carcinoma: common and familiar special types.Tavassoli F.A.Pathology of the breast.1999.Appleton & LangeStamford, CT:pp. 401-480.
10. Tavassoli F.A.: Ductal intraepithelial neoplasia.Tavassoli F.A.Pathology of the breast.1999.Appleton & LangeStamford, CT:pp. 265-295.
11. Dupont W.D., Page D.L.: Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985; 312: pp. 146-151.
12. Leconte I., Feger C., Galant C., et. al.: Mammography and subsequent whole-breast sonography of nonpalpable breast cancers: the importance of radiologic breast density. AJR Am J Roentgenol 2003; 180: pp. 1675-1679.
13. Kaplan S.S.: Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue. Radiology 2001; 221: pp. 641-649.
14. Stavros A.T., Thickman D., Rapp C.L., et. al.: Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 1995; 196: pp. 123-134.
15. Chung S.Y., Lee K.W., Park K.S., et. al.: Breast tumors associated with nipple discharge. Correlation of findings on galactography and sonography. Clin Imaging 1995; 19: pp. 165-171.
16. Satake H., Shimamoto K., Sawaki A., et. al.: Role of ultrasonography in the detection of intraductal spread of breast cancer: correlation with pathologic findings, mammography and MR imaging. Eur Radiol 2000; 10: pp. 1726-1732.
17. Kim K.W., Cho K.R., Seo B.K., et. al.: Findings of mammary duct ectasia: can malignancy be differentiated from benign disease?. J Breast Cancer 2010; 13: pp. 19-26.
18. Mayr N.A., Staples J.J., Robinson R.A., et. al.: Morphometric studies in intraductal breast carcinoma using computerized image analysis. Cancer 1991; 67: pp. 2805-2812.
19. Schoonjans J.M., Brem R.F.: Sonographic appearance of ductal carcinoma in situ diagnosed with ultrasonographically guided large core needle biopsy: correlation with mammographic and pathologic findings. J Ultrasound Med 2000; 19: pp. 449-457.
20. Izumori A., Takebe K., Sato A.: Ultrasound findings and histological features of ductal carcinoma in situ detected by ultrasound examination alone. Breast Cancer 2010; 17: pp. 136-141.
21. Menell J.H., Morris E.A., Dershaw D.D., et. al.: Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J 2005; 11: pp. 382-390.
22. Rosen E.L., Smith-Foley S.A., DeMartini W.B., et. al.: BI-RADS MRI enhancement characteristics of ductal carcinoma in situ. Breast J 2007; 13: pp. 545-550.